See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

The new bipartisan Senate bill aimed at making Big Pharma lower drug prices, explained

Posted on AllSides July 31st, 2019
From The Left

When it comes to government funding for drug research, an interesting paradox currently exists.

While many pharmaceutical companies benefit from federal funding for research, this doesn’t necessarily translate to lower prices for patients who ultimately buy the drugs that are developed. In other words, the government is effectively subsidizing companies’ ability to develop drugs and then charge exorbitant prices for them.

Sens. Chris Van Hollen (D-MD) and Rick Scott (R-FL) want to change that.

Their new bill, first provided to Vox, would require companies that have received research funding from...

Read full story

AllSides Picks

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right